References
- Beyer-Measr A, Crue E (1985): Reversal of diabetic cataract by sorbinyl, an aldose reductase inhibitor. Diabetes 34: 15–21.
- Endo Y, Masao M, Miura N, et al. (1998): Novel diterpenes and their use as antiviral and anti-HIV agents with toxicity. Jpn Kokai Tokkyo Koho 27: 10287617.
- Feng W, Ikekawa T, Yoshida M (1995): Antitumor activity of gnidimacrin isolated from Stellera chamaejasme. L. Chin J Oncol 17: 24–26.
- Feng B, Pei Y, Han B (2001): Flavonoids from root of Stellera chamaejasme.. Chin Tradit Herb Drugs 32: 14–15.
- Feng B, Pei Y, Hua H (2002): Flavonoids from Stellera chamaejasme. L. J Asian Nat Prod Res 4: 259–263. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Feng B, Pei Y, Hua H, Wang T, Zhang Y (2003): Biflavonoids from Stellera chamaejasme. L. Pharm Biol 41: 59–61.
- Handelsman DJ, Turtle JR (1981): Clinical trial of an aldose reductase inhibitor in diabetic neuropathy. Diabetes 30: 459–464. [PUBMED], [INFOTRIEVE]
- Ikekawa T, Ikekawa A (1996): Extraction of antitumor diterpenes from Stellera chamaejasme.. Jpn Kokai Tokkyo Koho 26: 08310993.
- Yoshida M, Feng W, Saijo N, Ikegawa T (1996): Antitumor activity of daphnane-type diterpene gnidimacrin isolated from Stellera chamaejasme. L. Int J Cancer 66: 268–273. [PUBMED], [INFOTRIEVE]